Show simple item record

AuthorDa'as S.I.
AuthorFakhro K.
AuthorThanassoulas A.
AuthorKrishnamoorthy N.
AuthorSaleh A.
AuthorCalver B.L.
AuthorSafieh-Garabedian B.
AuthorToft E.
AuthorNounesis G.
AuthorAnthony Lai F.
AuthorNomikos M.
Available date2019-09-24T08:16:00Z
Publication Date2018
Publication NameBiochemical Journal
AbstractThe most common inherited cardiac disorder, hypertrophic cardiomyopathy (HCM), is characterized by thickening of heart muscle, for which genetic mutations in cardiac myosin-binding protein C3 (c-MYBPC3) gene, is the leading cause. Notably, patients with HCM display a heterogeneous clinical presentation, onset and prognosis. Thus, delineating the molecular mechanisms that explain how disparate c-MYBPC3 variants lead to HCM is essential for correlating the impact of specific genotypes on clinical severity. Herein, five c-MYBPC3 missense variants clinically associated with HCM were investigated; namely V1 (R177H), V2 (A216T), V3 (E258K), V4 (E441K) and double mutation V5 (V3 + V4), all located within the C1 and C2 domains of MyBP-C, a region known to interact with sarcomeric protein, actin. Injection of the variant complementary RNAs in zebrafish embryos was observed to recapitulate phenotypic aspects of HCM in patients. Interestingly, V3- and V5-cRNA injection produced the most severe zebrafish cardiac phenotype, exhibiting increased diastolic/systolic myocardial thickness and significantly reduced heart rate compared with control zebrafish. Molecular analysis of recombinant C0?C2 protein fragments revealed that c-MYBPC3 variants alter the C0?C2 domain secondary structure, thermodynamic stability and importantly, result in a reduced binding affinity to cardiac actin. V5 (double mutant), displayed the greatest protein instability with concomitant loss of actin-binding function. Our study provides specific mechanistic insight into how c-MYBPC3 pathogenic variants alter both functional and structural characteristics of C0?C2 domains leading to impaired actin interaction and reduced contractility, which may provide a basis for elucidating the disease mechanism in HCM patients with c-MYBPC3 mutations. ? 2018 The Author(s).
SponsorState Scholarships Foundation
PublisherPortland Press Ltd
TitleHypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction
Pagination3933 - 3948
Issue Number24
Volume Number475

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record